Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.54B | 19.54B | 19.01B | 17.77B | 7.61B | 3.82B |
Gross Profit | 12.46B | 5.59B | 5.96B | 3.03B | -198.60M | -1.51B |
EBITDA | 3.45B | 5.71B | 5.62B | 5.17B | 1.42B | -2.43B |
Net Income | 3.39B | 2.78B | 2.67B | 2.16B | -962.00M | -4.27B |
Balance Sheet | ||||||
Total Assets | 43.09B | 43.09B | 44.26B | 50.19B | 49.72B | 37.58B |
Cash, Cash Equivalents and Short-Term Investments | 8.78B | 8.78B | 12.66B | 16.73B | 14.17B | 8.05B |
Total Debt | 12.91B | 12.91B | 13.45B | 15.34B | 15.92B | 14.34B |
Total Liabilities | 27.02B | 27.02B | 27.52B | 29.94B | 26.92B | 21.30B |
Stockholders Equity | 15.66B | 15.66B | 16.34B | 19.86B | 22.41B | 15.91B |
Cash Flow | ||||||
Free Cash Flow | 2.94B | 2.83B | 3.73B | 7.47B | -289.20M | -6.21B |
Operating Cash Flow | 4.71B | 4.71B | 5.05B | 9.15B | 2.83B | -3.44B |
Investing Cash Flow | -3.30B | -3.30B | -1.44B | -490.10M | -2.32B | -1.40B |
Financing Cash Flow | -4.33B | -4.33B | -8.78B | -5.88B | 5.44B | 9.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $33.71B | 10.43 | 27.70% | ― | 4.23% | 13.13% | |
81 Outperform | $32.73B | 15.60 | 27.12% | 1.34% | 10.61% | 37.32% | |
80 Outperform | $39.93B | 8.87 | 30.07% | 1.04% | 3.01% | -0.90% | |
68 Neutral | $15.98B | 7.71 | 17.47% | 6.03% | 3.30% | 4.36% | |
66 Neutral | $8.68B | 16.88 | -21.27% | ― | 1.50% | ― | |
64 Neutral | $10.95B | 16.37 | 8.81% | 1.96% | 2.68% | -15.33% | |
63 Neutral | $17.54B | 48.90 | 4.30% | 2.17% | 1.64% | 284.24% |